Current evidence on the anticancer potential of Chios mastic gum. (Q37951656)

25 August 2017

Current evidence on the anticancer potential of Chios mastic gum. (English)

1 reference

25 August 2017

2

Stamatios Theocharis

1 reference

25 August 2017

Constantinos Giaginis

series ordinal

1

1 reference

25 August 2017

1 November 2011

1 reference

25 August 2017

1 reference

25 August 2017

63

1 reference

25 August 2017

8

1 reference

25 August 2017

1174-1184

1 reference

A double-blind controlled clinical trial of mastic and placebo in the treatment of duodenal ulcer

25 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Chemical composition and antibacterial activity of the essential oil and the gum of Pistacia lentiscus Var. chia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Antimicrobial effect of mastic gum methanolic extract against Porphyromonas gingivalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

In vitro and in vivo activities of Chios mastic gum extracts and constituents against Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Evaluation of hepatoprotective effect of Pistacia lentiscus, Phillyrea latifolia and Nicotiana glauca

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

The effects of aqueous extracts prepared from the leaves of Pistacia lentiscus in experimental liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Chios mastic gum modulates serum biochemical parameters in a human population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Biological activity of some naturally occurring resins, gums and pigments against in vitro LDL oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Antiatherogenic effect of Pistacia lentiscus via GSH restoration and downregulation of CD36 mRNA expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Natural anti-inflammatory compounds for the management and adjuvant therapy of inflammatory bowel disease and its drug delivery system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Chios mastic gum extract and isolated phytosterol tirucallol exhibit anti-inflammatory activity in human aortic endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Bioassay-guided evaluation of anti-inflammatory and antinociceptive activities of pistachio, Pistacia vera L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

A pilot study on antiplaque effects of mastic chewing gum in the oral cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Alterations in the function of circulating mononuclear cells derived from patients with Crohn's disease treated with mastic

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Mechanisms of antiprostate cancer by gum mastic: NF-kappaB signal as target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Gum mastic increases maspin expression in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Gum mastic inhibits the expression and function of the androgen receptor in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

A transcriptomic computational analysis of mastic oil-treated Lewis lung carcinomas reveals molecular mechanisms targeting tumor cell growth and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Protective effects of mastic oil from Pistacia lentiscus variation chia against experimental growth of lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Antiproliferative activity and induction of apoptosis in human colon cancer cells treated in vitro with constituents of a product derived from Pistacia lentiscus L. var. chia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Mastic oil from Pistacia lentiscus var. chia inhibits growth and survival of human K562 leukemia cells and attenuates angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Gemcitabine combined with gum mastic causes potent growth inhibition and apoptosis of pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Cytotoxic activity and effect on nitric oxide production of tirucallane-type triterpenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

A new sesquiterpene and other terpenoid constituents of Chisocheton penduliflorus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Growth inhibition of rat liver epithelial tumor cells by monoterpenes does not involve Ras plasma membrane association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Protective effect of linalool, myrcene and eucalyptol against t-butyl hydroperoxide induced genotoxicity in bacteria and cultured human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

A sugar ester and an iridoid glycoside from Scrophularia ningpoensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Oleanolic acid and ursolic acid induce apoptosis in four human liver cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Cytotoxic triterpenes from the aerial roots of Ficus microcarpa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Protective effects of ursolic acid and oleanolic acid in leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Protective effects of ursolic acid and luteolin against oxidative DNA damage include enhancement of DNA repair in Caco-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Synthesis and anti-human hepatocellular carcinoma activity of new nitric oxide-releasing glycosyl derivatives of oleanolic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Plant-derived triterpenoids as potential antineoplastic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Triterpenoids display single agent anti-tumor activity in a transgenic mouse model of chronic lymphocytic leukemia and small B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Therapeutic potential of synthetic triterpenoids in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Triterpenoids as new promising anticancer drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Apoptotic activity and mechanism of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic-acid and related synthetic triterpenoids in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

High sensitivity of ovarian cancer cells to the synthetic triterpenoid CDDO-Imidazolide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells through a ROS-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Human neuroblastoma cells rapidly enter cell cycle arrest and apoptosis following exposure to C-28 derivatives of the synthetic triterpenoid CDDO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Synthetic triterpenoids inhibit growth and induce apoptosis in human glioblastoma and neuroblastoma cells through inhibition of prosurvival Akt, NF-kappaB and Notch1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Methyl 2-cyano-3,11-dioxo-18-olean-1,12-dien-30-oate (CDODA-Me), a derivative of glycyrrhetinic acid, functions as a potent angiogenesis inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Cucurbitacin: ancient compound shedding new light on cancer treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Chemical and biological characterization of oleanane triterpenoids from soy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

Terpenoids: natural inhibitors of NF-kappaB signaling with anti-inflammatory and anticancer potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.607546

10.1080/01635581.2011.607546

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

22044444